Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

54 Scopus Citations
View graph of relations



Original languageEnglish
Article number2242
Journal / PublicationNature Communications
Online published14 Apr 2021
Publication statusPublished - 2021



Breast cancer is a heterogeneous disease, affecting over 3.5 million women worldwide, yet the functional role of cis-regulatory elements including super-enhancers in different breast cancer subtypes remains poorly characterized. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a poor prognosis. Here we apply integrated epigenomic and transcriptomic profiling to uncover super-enhancer heterogeneity between breast cancer subtypes, and provide clinically relevant biological insights towards TNBC. Using CRISPR/Cas9-mediated gene editing, we identify genes that are specifically regulated by TNBC-specific super-enhancers, including FOXC1 and MET, thereby unveiling a mechanism for specific overexpression of the key oncogenes in TNBC. We also identify ANLN as a TNBC-specific gene regulated by super-enhancer. Our studies reveal a TNBC-specific epigenomic landscape, contributing to the dysregulated oncogene expression in breast tumorigenesis.

Research Area(s)

Citation Format(s)

Download Statistics

No data available